Funding for this research was provided by:
National Institutes of Health (R41HG010126, R01HG009141, U24CA209999)
Received: 11 December 2019
Accepted: 1 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: All procedures related to acquisition and use of data from glioma patients were approved by the University of Utah Internal Review Board prior to study initiation (protocol #10924) and conform to the principles of the Helsinki Declaration. All glioma patients provided written informed consent.
: Not applicable
: Brent S. Pedersen and Aaron R. Quinlan are co-founders of Base2 Genomics. The remaining authors declare that they have no competing interests.